Krilogy Financial’s Gossamer Bio GOSS Stock Holding History

Krilogy Financial’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-134	Closed	-$1.76K	–	1124
2026 Q2	$1.76K	Sell	134 -74	-36%	-$1.65K	﹤0.01%	1071
2026 Q1	$7.27K	Buy	+208	New	+$26.2K	﹤0.01%	980

Other funds holding GOSS

Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Worth Venture Partners Fort Lee, New Jersey $38.9M AUM 12.3% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

KCM

Kalehua Capital Management Dallas, Texas $132M AUM 92.09% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Krilogy Financial's GOSS Position: Q3 2026 in Review

Krilogy Financial sold out of Gossamer Bio (GOSS) in Q3 2026, closing a stake of 134 shares — an estimated $1.76K sold.

Krilogy Financial first reported a position in GOSS in Q1 2026 and held it in 2 quarters. The position peaked at $7.27K in Q1 2026. 50 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.

Krilogy Financial reported no remaining Gossamer Bio position as of Q3 2026 after selling out during the quarter.
Krilogy Financial sold 134 Gossamer Bio shares in Q3 2026, an estimated $1.76K.
Krilogy Financial first reported a position in Gossamer Bio in Q1 2026 and held it in 2 quarters.
Krilogy Financial's Gossamer Bio position peaked at $7.27K in Q1 2026.
50 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.

Based on Krilogy Financial's 13F filing for Q3 2026, filed 13 Oct 2026.